Evaluation of BBG2Na in infant macaques:: specific immune responses after vaccination and RSV challenge

被引:37
作者
de Waal, L
Power, UF
Yüksel, S
van Amerongen, G
Nguyen, TN
Niesters, HGM
de Swart, RL
Osterhaus, ADME
机构
[1] Erasmus MC, Dept Virol, NL-3000 DR Rotterdam, Netherlands
[2] CIPF, F-74164 St Julien En Genevois, France
关键词
BBG2Na; RSV; immunopathology;
D O I
10.1016/j.vaccine.2003.10.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have addressed the safety of alum-adsorbed BBG2Na, a recombinant respiratory syncytial virus (RSV) subunit vaccine, in infant macaques. Animals received two vaccinations, and were challenged 4 months later with RSV. In two of four BBG2Na-vaccinated animals, specific IL-13 producing T cells were detected. Upon challenge, low level pulmonary eosinophilia was observed in the same two animals. Although the levels of these responses were substantially lower than those observed in the FI-RSV controls, these data suggest that more extensive studies focusing on immunopathological safety of alum-adsorbed BBG2Na in non-human primates would be required before proceeding to clinical trials in seronegative infants. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:915 / 922
页数:8
相关论文
共 20 条
[1]   Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide [J].
Corvaia, N ;
Tournier, P ;
Nguyen, TN ;
Haeuw, JF ;
Power, UF ;
Binz, H ;
Andreoni, C .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (03) :560-569
[2]   Respiratory syncytial virus vaccine development [J].
Crowe, JE .
VACCINE, 2001, 20 :S32-S37
[3]   A novel bipolar mode of attachment to aluminium-containing adjuvants by BBG2Na, a recombinant subunit hRSV vaccine [J].
Dagouassat, N ;
Robillard, V ;
Haeuw, JF ;
Plotnicky-Gilquin, H ;
Power, UF ;
Corvaïa, N ;
Nguyen, T ;
Bonnefoy, JY ;
Beck, A .
VACCINE, 2001, 19 (30) :4143-4152
[4]   Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection [J].
de Swart, RL ;
Kuiken, T ;
Timmerman, HH ;
van Amerongen, G ;
van den Hoogen, BG ;
Vos, HW ;
Neijens, HJ ;
Andeweg, AC ;
Osterhaus, ADME .
JOURNAL OF VIROLOGY, 2002, 76 (22) :11561-11569
[5]   ALTERED REACTIVITY TO MEASLES VIRUS - ATYPICAL MEASLES IN CHILDREN PREVIOUSLY IMMUNIZED WITH INACTIVATED MEASLES VIRUS VACCINES [J].
FULGINITI, VA ;
ELLER, JJ ;
DOWNIE, AW ;
KEMPE, CH .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 202 (12) :1075-+
[6]   Respiratory syncytial virus immunobiology and pathogenesis [J].
Graham, BS ;
Rutigliano, JA ;
Johnson, TR .
VIROLOGY, 2002, 297 (01) :1-7
[7]   RESPIRATORY SYNCYTIAL VIRUS DISEASE IN INFANTS DESPITE PRIOR ADMINISTRATION OF ANTIGENIC INACTIVATED VACCINE [J].
KIM, HW ;
CANCHOLA, JG ;
BRANDT, CD ;
PYLES, G ;
CHANOCK, RM ;
JENSEN, K ;
PARROTT, RH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 89 (04) :422-+
[8]   Immunopathogenesis of vaccine-enhanced RSV disease [J].
Openshaw, PJM ;
Culley, FJ ;
Olszewska, W .
VACCINE, 2001, 20 :S27-S31
[9]   Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate [J].
Plotnicky, H ;
Siegrist, CA ;
Aubry, JP ;
Bonnefroy, JY ;
Corvaïa, N ;
Nguyen, TN ;
Power, UF .
VACCINE, 2003, 21 (19-20) :2651-2660
[10]   Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment [J].
Plotnicky-Gilquin, H ;
Huss, T ;
Aubry, JP ;
Haeuw, JF ;
Beck, A ;
Bonnefoy, JY ;
Nguyen, TN ;
Power, UF .
VIROLOGY, 1999, 258 (01) :128-140